email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
2641 - 2655
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Sinovant In-licenses China Rights to HGH Mimetic from Angion
$5.00
Available
Innovent's NDA Filing for Humira Biosimilar Accepted in China
$5.00
Available
LG Chem Forms IO Collaboration Worth Up to $1 Billion with Cue Biopharma
$5.00
Available
Generon to Start China Phase I Trial of IO Drug in B Cell Malignancies
$5.00
Available
bioM
$5.00
Available
Denmark's Ascendis Forms $80 Million China Rare Disease JV with Vivo Capital
$5.00
Available
Innovent Starts Phase III Trial of PD-1 Candidate in Lung Cancer Patients
$5.00
Available
Berry Genomics and Prenetics Team up to Offer Consumer Genetic Testing
$5.00
Available
HuiyiHuiying Raises Funds from Intel for Medical Imaging AI
$5.00
Available
Ping An Good Doctor Announces AI-Based Freestanding One-Minute Clinics
$5.00
Available
Zhejiang Jingxin Makes $10 Million Investment in Mapi Pharma of Israel
$5.00
Available
Ocumension Acquires China Rights to Uveitis Treatment in $12 Million Agreement
$5.00
Available
Shanghai Stock Exchange to Set Up New Board for Innovative Science and Tech Companies
$5.00
Available
I-Mab Approved to Start China Trials of Interleukin-7 Immunotherapy
$5.00
Available
Bio-Thera Starts China Phase III Trial of HER2 Conjugate Drug
$5.00
Available